LINC00963 and prostate cancer: LINC00963 could serve as an oncogene by regulating biological processes, including survival, metastasis, and differentiation (47), was up-regulated in prostate cancer (48), hepatocellular carcinoma (49), osteosarcoma (50), and cutaneous squamous cell carcinoma (51, 52).